Drug profile · INN
tyropanoate sodium
BILOPAQUE
tyropanoate sodium (BILOPAQUE) is an FDA-listed pharmaceutical active ingredient. Route of administration: oral. Current US regulatory status: approved.
Drug details — tyropanoate sodium
- US status
- approved
- Class
- —
- Route
- ORAL
- Patents
- 0
- Programs
- 0
- Data quality
- 0.84
Quick answer
tyropanoate sodium (BILOPAQUE) is an FDA-listed pharmaceutical active ingredient. Route of administration: oral. Current US regulatory status: approved.
Key facts
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Frequently asked questions
What is tyropanoate sodium?
tyropanoate sodium (BILOPAQUE) is an FDA-listed pharmaceutical active ingredient. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for tyropanoate sodium?
BILOPAQUE is a marketed brand name for tyropanoate sodium. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of tyropanoate sodium?
tyropanoate sodium has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.